Market Tracker

08/30 3:01pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

10.19
Delayed Data
As of 2:46pm ET
 +0.15 / +1.49%
Today’s Change
9.23
Today|||52-Week Range
55.47
-72.00%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close10.04
Today’s open10.14
Day’s range10.04 - 10.36
Volume92,701
Average volume (3 months)548,215
Market cap$290.8M
Dividend yield--
Data as of 2:46pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-116.31%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-0.17-1.30%
CRVSCorvus Pharmaceutica...+0.12+0.85%
COCPCocrystal Pharma Inc-0.01-2.98%
PRTKParatek Pharmaceutic...-0.02-0.15%
Data as of 3:00pm ET, 08/30/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts